Clinical Trial Update: iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study [NA]

View source ↗

Summary

Post-market clinical follow-up study of the iCLAS Cryoablation System by Adagio Medical has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation

Drugs mentioned

• iCLAS Cryoablation System (cryoablation system)

Snippet

Sponsor: Adagio Medical | Conditions: Atrial Fibrillation, Atrial Flutter | NA | Status: TERMINATED